Negjyp Sopa, Klinikchef

Negjyp Sopa

Ever since I started studying medicine, I have known that my greatest desire was to specialise in gynaecology and obstetrics. After I achieved my first goal and became a gynaecologist, I got even more interested in infertility and reproduction. It gives me the opportunity to be part of a fantastic journey together with all our clients and to make a unique difference in their lives. As one of the only people in Denmark, I have therefore also taken a degree as an expert in human reproduction and fertility, which focuses on research, dissemination of results and clinical work.

After many years of experience with fertility treatment at various clinics in both Denmark and abroad, in the public sector and in private practice, I have chosen to work at Aleris Fertility, because the clinic is part of the largest and most prestigious private hospital in Scandinavia.

In my work, I attach importance to accountability and to creating great results in combination with professional, individual and caring patient treatment.

Education and training

  • 1992: Master of Science in Medicine
  • 2005: Specialist in Gynaecology and Obstetrics

Relevant supplementary and further education and training

  • 2006: Subspecialisation in Fertility
  • 2019: Expert in Human Reproduction and Fertility

Work experience

  • 2017 – 2019: The Fertility Clinic at Hvidovre Hospital
  • 2006 – 2017: The Fertility Clinic at Rigshospitalet (Copenhagen University Hospital)
  • 2005 – 2006: The Fertility Clinic at Dronninglund Hospital, which is part of Aalborg Hospital

Special competences and areas of interest

  • Expert in Human Reproduction and Fertility

Teaching

  • 2002-2006 (October), external lecturer at Health CDE Aalborg, Midwifery Training College.
  • From 2015, teaching of medical students in reproduction and infertility at all three University Hospitals: Rigshospitalet, Herlev Hospital and Hvidovre Hospital.

Professional memberships

  • From 2005 member of the Danish Society for Gynaecology and Obstetrics (DSOG)
  • From 2005 Member of the European Society of Human Reproduction and Embryology (ESHRE)
  • From 2006 Member of the Nordic Fertility Society (NFS)
  • From 2005 Member of the Danish Fertility Society (DFS)

Other relevant information

  • Co-author of various guidelines for reproduction and fertility.
  • Society of Endometriosis and Uterine Disorders (SEUD)
  • Instituto Valenciano de Infertilidad (IVI)

Science & Teaching

Studies in relevant field:

  • Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial Human Reproduction, Volume 38, Issue 11, november 2023, Pages 2154–2165, https://doi.org/10.1093/humrep/dead182
  • Psychosocial wellbeing shortly after allocation to a freeze-all strategy compared with a fresh transfer strategy in women and men: a sub-study of a randomized controlled trial. Human Reprod 2023 Nov 2;38(11):2175-2186. doi: 10.1093/humrep/dead188 https://doi.org/10.1093/humrep/dead188 
  • Ovarian morphology and length of follicular phase differ between immediate and postponed modified natural-cycle frozen embryo transfer (mNC-FET) cycles – Sub-study of an ongoing RCT Human Reproduction, Volume 38, Issue Supplement_1, June 2023, dead093.1096, https://doi.org/10.1093/humrep/dead093.1096
  • Impact of letrozole cO-treatment during ovarian stimulation on the oocyte yield, embryo development, and live birth rate – a randomised controlled trial (RIOT) Human Reproduction, Volume 37, Issue Supplement_1, July 2022, deac105.026, https://doi.org/10.1093/humrep/deac105.026
  • Cumulative live birth rates in a freeze-all and fresh transfer strategy after one complete ART cycle in ovulatory women Human Reproduction, Volume 37, Issue Supplement_1, July 2022, deac106.083, https://doi.org/10.1093/humrep/deac106.083
  • Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial. Human Reproduction 2022 Jan 28;37(2):309-321. https://doi.org/10.1093/humrep/deab249
  • Impact of letrozole co-treatment during ovarian stimulation with gonadotropins for in vitro fertilisation (IVF): a multicentre, randomised, double-blinded placebo-controlled trial. Human Reproduction, Volume 36, Issue Supplement_1, July 2021, deab128.053, https://doi.org/10.1093/humrep/deab128.053
  • “Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trail”. Read article here
  • ”Embryo Morphokinetics and Blastocyst Development After GnRH Agonist versus hCG Triggering in Normo-ovulatory Women: a Secondary Analysis of a Multicenter Randomized Controlled Trial”. Read article here
  • ”Freeze-all versus fresh blastocyst transfer strategy during in vitro fertilisation in women with regular menstrual cycles: multicentre randomised controlled trial”. Read article here
  • “An AMH-based FSH dosing algorithm for OHSS risk reduction in first cycle antagonist protocol for IVF/ICSI.”. Read article here
  • “Anti-Müllerian Hormone (AMH) is A Good Predictor for Ongoing Pregnancy in Women Undergoing IVF/ICSI in Antagonist Cycles.”. Read article here
  • “Low dose HP-hMG in an antagonist protocol for IVF in ovulatory and anovulatory patients with high AMH”. Read article here
  • “Post laparoscopic massive vulvar edema in woman with ovarian hyperstimulation syndrome.”. Read article here
  • “A Case with Severe Endometriosis, Ovarian Hyperstimulation Syndrome, and Isolated Unilateral Pleural Effusion after IVF”. Read article here
  • “Selective use of corifollitropin for controlled ovarian stimulation for IVF in patients with low anti-Müllerian hormone”. Read article here